Tag: B7-H3 Targeted Immunotherapy

Home / B7-H3 Targeted Immunotherapy

Categories

Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma

March 2023: Study Type : Interventional (Clinical Trial)Estimated Enrollment : 30 participantsAllocation: N/AIntervention Model: Sequential AssignmentIntervention Model Description: a "3+3" d...
b7-h3-targeted-immunotherapy

Scan the code